Abstract
In the 20 yr since the discovery of proteins whose levels oscillate during the cell cycle in marine invertebrate embryos (1), the study of cyclins and their cognate protein kinases has revealed a wealth of information on how eukaryotic cells control cyclical functions connected with cell proliferation and growth. The picture that has emerged from two decades of investigation is intricate and still incomplete. In the simplest possible model, cyclins are critical regulatory subunits of cyclin-dependent protein kinases (CDKs). When cyclin levels rise, they form stable complexes with CDKs, generating enzymatically active heterodimeric complexes. When cyclin levels fall, CDKs lose catalytic activity and are unable to phosphorylate their substrates. This simple model remains fundamentally valid, but it is now clear that the regulation of cyclin/CDKs is exquisitely complex throughout the cell cycle. Moreover, it is now widely recognized that cyclins and CDKs do much more than simply control cell cycle progression. The relatively simple mechanisms discovered in yeast cells, which have one G1 cyclin, one G2 cyclin, and a single CDK, are replaced in mammalian cells by a richly redundant molecular network, including multiple cyclins, CDKs, and regulatory pathways that cross-talk with a dizzying array of cell fate determination molecules. Thus, it is hardly surprising that initial hopes for quick discovery and therapeutic development of highly specific pharmacological inhibitors of cyclin/CDK complexes have not yet been fully realized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Evans, T., Rosenthal, E. T., Youngblom, J., Distel, D., and Hunt, T. (1983) Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33, 389–396.
Blagosklonny, M. V. and Pardee, A. B. (2002) The restriction point of the cell cycle. Cell Cycle 1, 103–110.
Sherr, C. J. (1995). D-type cyclins. Trends Biochem. Sci. 20, 187–190.
Hunter, T. and Pines, J. (1994) Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79, 573–582.
Coqueret, O. (2002) Linking cyclins to transcriptional control. Gene 299, 35–55.
Morgan, D. O. (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261–291.
Morgan, D. O. (1995) Principles of CDK regulation. Nature 374, 131–134.
Russell, P. and Nurse, P. (1987) Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell 49, 559–567.
Russell, P. and Nurse, P. (1986) cdc25+ functions as an inducer in the mitotic control of fission yeast. Cell 45, 145–153.
Harbour, J. W. and Dean, D. C. (2000) Chromatin remodeling and Rb activity. Curr. Opin. Cell Biol. 12, 685–689.
Harbour, J. W. and Dean, D. C. (2001) Corepressors and retinoblastoma protein function. Curr. Top. Microbiol. Immunol. 254, 137–144.
Harbour, J. W., Luo, R. X., Dei, S. A., Postigo, A. A., and Dean, D. C. (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859–869.
Harbour, J. W. and Dean, D. C. (2000) Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol. 2, E65–E67.
Harbour, J. W. and Dean, D. C. (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393–2409.
Sherr, C. J. (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689–3695.
Sherr, C. J. and Roberts, J. M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512.
Enders, G. H. (2003) The INK4a/ARF locus and human cancer. Methods Mol. Biol. 222, 197–209.
Ortega, S., Malumbres, M., and Barbacid, M. (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602, 73–87.
Shapiro, G. I. and Harper, J. W. (1999) Anticancer drug targets: cell cycle and checkpoint control. J. Clin. Invest. 104, 1645–1653.
Lowe, S. W. and Sherr, C. J. (2003) Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77–83.
Sherr, C. J. and McCormick, F. (2002) The RB and p53 pathways in cancer. Cancer Cell 2, 103–112.
Tetsu, O. and McCormick, F. (2003) Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 3, 233–245.
Nickoloff, B. J., Osborne, B. A., and Miele, L. (2003) Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 22, 6598–6608.
Yu, Z. K., Gervais, J. L., and Zhang, H. (1998) Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc. Natl. Acad. Sci. USA 95, 11,324–11,329.
Diehl, J. A., Cheng, M., Roussel, M. F., and Sherr, C. J. (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499–3511.
Diehl, J. A., Zindy, F., and Sherr, C. J. (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11, 957–972.
Lustig, B. and Behrens, J. (2003) The Wnt signaling pathway and its role in tumor development. J. Cancer Res. Clin. Oncol. 129, 199–221.
Manoukian, A. S. and Woodgett, J. R. (2002) Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv. Cancer Res. 84, 203–229.
Raught, B., Gingras, A. C., and Sonenberg, N. (2001) The target of rapamycin (TOR) proteins. Proc. Natl. Acad. Sci. USA 98, 7037–7044.
Schmelzle, T. and Hall, M. N. (2000) TOR, a central controller of cell growth. Cell 103, 253–262.
Thomas, G. and Hall, M. N. (1997) TOR signalling and control of cell growth. Curr. Opin. Cell Biol. 9, 782–787.
Duman-Scheel, M., Weng, L., Xin, S., and Du, W. (2002) Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E. Nature 417, 299–304.
Shoker, B. S., Jarvis, C., Davies, M. P., Iqbal, M., Sibson, D. R., and Sloane, J. P. (2001) Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br. J. Cancer 84, 1064–1069.
Zwijsen, R. M., Buckle, R. S., Hijmans, E. M., Loomans, C. J., and Bernards, R. (1998) Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev. 12, 3488–3498.
McMahon, C., Suthiphongchai, T., DiRenzo, J., and Ewen, M. E. (1999) P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc. Natl. Acad. Sci. USA 96, 5382–5387.
Lin, H. M., Zhao, L., and Cheng, S. Y. (2002) Cyclin D1 is a ligand-independent co-repressor for thyroid hormone receptors. J. Biol. Chem. 277, 28,733–28,741.
Adnane, J., Shao, Z., and Robbins, P. D. (1999) Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription. Oncogene 18, 239–247.
Sicinski, P. and Weinberg, R. A. (1997) A specific role for cyclin D1 in mammary gland development. J. Mammary Gland. Biol. Neoplasia. 2, 335–342.
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., et al. (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621–630.
Geng, Y., Whoriskey, W., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., et al. (1999) Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97, 767–777.
Ye, X., Wei, Y., Nalepa, G., and Harper, J. W. (2003) The cyclin E/Cdk2 substrate p220(NPAT) is required for S-phase entry, histone gene expression, and cajal body maintenance in human somatic cells. Mol. Cell Biol. 23, 8586–8600.
Zhao, J., Kennedy, B. K., Lawrence, B. D., Barbie, D. A., Matera, A. G., Fletcher, J. A., et al. (2000) NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev. 14, 2283–2297.
Yam, C. H., Fung, T. K., and Poon, R. Y. (2002) Cyclin A in cell cycle control and cancer. Cell Mol. Life Sci. 59, 1317–1326.
Nevins, J. R., Chellappan, S. P., Mudryj, M., Hiebert, S., Devoto, S., Horowitz, J., et al. (1991) E2F transcription factor is a target for the RB protein and the cyclin A protein. Cold Spring Harb. Symp. Quant. Biol. 56, 157–162.
O’Farrell, P. H. (2001) Triggering the all-or-nothing switch into mitosis. Trends Cell Biol. 11, 512–519.
Mueller, P. R., Coleman, T. R., Kumagai, A., and Dunphy, W. G. (1995) Myt1: a membrane-associated inhibitory kinase that phosphorylates cdc2 on both threonine-14 and tyrosine-15. Science 270, 86–90.
Nigg, E. A. (2001) Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2, 21–32.
Nigg, E. A. (2001) Cell cycle regulation by protein kinases and phosphatases. Ernst. Schering. Res. Found. Workshop 19–46.
Lim, H. H. and Surana, U. (2003) Tome-1, wee1, and the onset of mitosis: coupled destruction for timely entry. Mol. Cell 11, 845–846.
Ayad, N. G., Rankin, S., Murakami, M., Jebanathirajah, J., Gygi S., and Kirschner, M. W. (2003) Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell 113, 101–113.
Dai, W., Huang, X., and Ruan, Q. (2003) Polo-like kinases in cell cycle checkpoint control. Front Biosci. 8, d1128–d1133.
Dai, W., Wang, Q., and Traganos, F. (2002) Polo-like kinases and centrosome regulation. Oncogene 21, 6195–6200.
Fry, A. M. (2002) The Nek2 protein kinase: a novel regulator of centrosome structure. Oncogene 21, 6184–6194.
Ye, X. S. and Osmani, S. A. (1997) Regulation of p34cdc2/cyclinB H1 and NIMA kinases during the G2/M transition and checkpoint responses in Aspergillus nidulans. Prog. Cell Cycle Res. 3, 221–232.
Ke, Y. W., Dou, Z., Zhang, J., and Yao, X. B. (2003) Function and regulation of Aurora/Ipl1p kinase family in cell division. Cell Res. 13, 69–81.
Adams, R. R., Carmena, M., and Earnshaw, W. C. (2001) Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol. 11, 49–54.
Goepfert, T. M. and Brinkley, B. R. (2000) The centrosome-associated aurora/Ipl-like kinase family. Curr. Top. Dev. Biol. 49, 331–342.
Shiekhattar, R., Mermelstein, F., Fisher, R. P., Drapkin, R., Dynlacht, B., Wessling, H. C., et al. (1995) Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374, 283–287.
Lin, X., Taube, R., Fujinaga, K., and Peterlin, B. M. (2002) P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA. J. Biol. Chem. 277, 16,873–16,878.
Taube, R., Lin, X., Irwin, D., Fujinaga, K., and Peterlin, B. M. (2002) Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol. Cell Biol. 22, 321–331.
Buolamwini, J. K. (2000) Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm. Des. 6, 379–392.
Senderowicz, A. M. (2003) Small-molecule cyclin-dependent kinase modulators. Oncogene 22, 6609–6620.
Fischer, P. M. (2001) Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors. Curr. Opin. Drug Dis. Dev. 4, 623–634.
Chen, Y. N., Sharma, S. K., Ramsey, T. M., Jiang, L., Martin, M. S., Baker, K., et al. (1999) Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc. Natl. Acad. Sci. USA 96, 4325–4329.
Castedo, M., Perfettini, J. L., Roumier, T., and Kroemer, G. (2002) Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ. 9, 1287–1293.
Seong, Y. S., Min, C., Li, L., Yang, J. Y., Kim, S. Y., Cao, X., et al. (2003) Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026. Cancer Res. 63, 7384–7391.
Dragnev, K. H., Freemantle, S. J., Spinella, M. J., and Dmitrovsky, E. (2001) Cyclin proteolysis as a retinoid cancer prevention mechanism. Ann. N.Y. Acad. Sci. 952, 13–22.
Rolfe, M., Chiu, M. I., and Pagano, M. (1997) The ubiquitin-mediated proteolytic pathway as a therapeutic area. J. Mol. Med. 75, 5–17.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Miele, L. (2004). The Biology of Cyclins and Cyclin-Dependent Protein Kinases. In: Giordano, A., Romano, G. (eds) Cell Cycle Control and Dysregulation Protocols. Methods in Molecular Biology™, vol 285. Humana Press. https://doi.org/10.1385/1-59259-822-6:003
Download citation
DOI: https://doi.org/10.1385/1-59259-822-6:003
Publisher Name: Humana Press
Print ISBN: 978-0-89603-949-0
Online ISBN: 978-1-59259-822-9
eBook Packages: Springer Protocols